Imaging of pancreatic adenocarcinoma with radiolabeled monoclonal antibodies

Annals of Oncology

Volumn 10, Issue SUPPL. 4, 1999, Pages

  Mariani, Giuliano ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b DIMI   (Italy)

Author keywords

Immunoscintigraphy; Monoclonal antibodies; Pancreatic adenocarcinoma; Radioimmunotherapy; Tumor associated antigens

Indexed keywords

MONOCLONAL ANTIBODY;

BONE MARROW; CONFERENCE PAPER; HUMAN; IMAGE ANALYSIS; IMMUNOSCINTIGRAPHY; KIDNEY; LIVER; PANCREAS ADENOCARCINOMA; PERITONEUM CANCER; PRIORITY JOURNAL; RADIOACTIVITY; RADIOIMMUNOTHERAPY; SPLEEN;

EID: 0032807707     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/10.suppl_4.S37     Document Type: Conference Paper

References (36)

1. Boring CC, Squires TS, Tong T et al. Cancer Statistics, 1994. CA 1994; 44: 7-26.
2. Evans DB, Abbruzzese JL, Rich TA. Cancer of the pancreas. In: Cancer. Principles & Practice of Oncology, 5th Edition. DeVita VT Jr, Hellman S, Rosenberg SA, eds. Philadelphia - New York: Lippincott-Raven 1997: 1054-87.
3. Di Magno EP. Pancreatic adenocarcinoma. In: Textbook of Gastroenterology, 2nd Edition. Yamada T, Alpers DH, Owyang C et al, eds. Philadelphia: JB Lippincott 1995: 2113-31.
4. Mittelstaedt CA. Pancreas. In General Ultra-sound. Mittelstaedt CA, ed. New York: Churchill Livingstone 1992: 371-448.
5. Stanley RJ, Semelka RC. Pancreas. In: Computed Body Tomography with MRI Correlation. Lee JKT, Sagel SS, Stanley RJ et al, eds. Philadelphia - New York: Lippincott-Raven 1998: 873-960.
6. Schlom J. Basic principles and applications of monoclonal antibodies in the management of carcinomas: The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 1986; 46: 3225-38.
7. Waldmann TA. Monoclonal antibodies in diagnosis and therapy. Science 1991; 252: 1657-62.
8. Goldenberg DM, Larson SM. Radioimmuno-detection in cancer identification. J Nucl Med 1992; 33: 803-14.
9. Prat M, Morra I, Bussolati G et al. CAR-3, a monoclonal antibody-defined antigen expressed on human adenocarcinomas. Cancer Res 1985; 45: 5799-807.
10. Prat M, Medico E, Rossino P et al. Biochemical and immunological properties of the human carcinoma-associated CAR-3 epitope defined by the monoclonal antibody AR-3. Cancer Res 1989; 49: 1415-21.
11. Gold DV, Lew K, Maliniak R et al. Characterization of monoclonal antibody PAM4 reactive with a pancreatic cancer mucin. Int J Cancer 1994; 57: 204-10.
12. Montz R, Klapdor R, Kremer B et al. Immunoscintigraphy and SPECT in patients with pancreatic cancer. Nuklearmedizin 1985; 24: 232-7.
13. Montz R, Klapdor R, Rothe B et al. Immunoscintigraphy and radioimmunotherapy in patients with pancreatic carcinoma. Nuklearmedizin 1986; 25: 239-44.
14. Bosslet K, Schwarz A, Steinstraesser A et al. Immunoscintigraphy of colorectal cancers and specific immunotherapy of pancreatic cancers using monoclonal antibodies. Wien Med Wochenschr 1988; 138: 255-7.
15. Ditzel H, Rasmussen JW, Borup Christensen P, Erb K, Jensenius JC. Immunoscintigraphy of colon cancers with the human monoclonal antibody COU-1. Cancer 1994; 73 (suppl 3): 858-63.
16. Mariani G, Molea N, Bacciardi D et al. Biodistribution and pharmacokinetic screening in humans of monoclonal antibody AR-3 as a possible immunoscintigraphy agent in patients with pancreatic cancer. J Nucl Biol Med 1994; 38 (suppl 4): 145-50.
17. Mariani G, Molea N, Bacciardi D et al. Initial tumor targeting, biodistribution and pharmacokinetic evaluation of the monoclonal antibody PAM4 in patients with pancreatic cancer. Cancer Res 1995; 55 (suppl): 5911s-5s.
18. 131I-labeled monoclonal antibodies against CA19-9, CEA and CA125. Nuklearmedizin 1985; 24: 227-31.
19. Nakamura K, Kubo A, Hashimoto S et al. Radioimmuno-detection of human pancreatic tumor xenografts using DU-PAN II monoclonal antibody. Ann Nucl Med 1988; 2: 1-6.
20. Otsuji E, Yamaguchi T, Yamaoka N et al. Biodistribution of murine and chimeric Fab fragments of the monoclonal antibody A7 in human pancreatic cancer. Pancreas 1995; 10: 265-73.
21. Jiang Y. Immunoscintigraphy of human pancreatic cancer: An experimental study. Chung Hua Chung Liu TYsa Chih 1993; 15: 198-201.
22. Otsuji E, Yamaguchi T, Yamaoka N et al. Enhanced tumor localization of radiolabeled Fab fragments of monoclonal antibody A7 in nude mice bearing human pancreatic carcinoma xenografts. Jpn J Cancer Res 1993; 84: 914-20.
23. 2 fragmentation in athymic nude mice bearing human pancreatic carcinomas. J Surg Oncol 1993; 53: 168-74.
24. Hoh CK, Schiepers C, Seltzer MA et al. PET in oncology: Will it replace the other modalities? Semin Nucl Med 1997; 27: 94-106.
25. Warburg O. On the origin of cancer cells. Science 1956; 123: 309-14.
26. Weber G. Enzymology of cancer cells. N Engl J Med 1977; 296: 486-93.
27. Flier JS, Mueckler MM, Usher SC et al. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 1987; 235: 1492-5.
28. Hawkins RA, Choi Y, Huang SC et al. Quantitating tumor glucose metabolism with FDG and PET. J Nucl Med 1991; 32: 616-22.
29. Stollfuss JC, Glatting G, Friess H et al. 2-(Fluorine-18)-fluoro-deoxy-D-glucose PET in detection of pancreatic cancer: Value of quantitative image interpretation, radiology 1995; 195: 339-44.
30. Inokuma T, Tamaki N, Torizuka T et al. Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxy-glucose: comparison with CT and US, radiology 1995; 195: 345-52.
31. 18F] fluoro-2-deoxy-D-glucose positron emission tomography. Gut 1995; 36: 771-7.
32. Bares R, Dohmen BM, Cremerius U et al. Results of positron emission tomography with fluorine-18 labeled fluorodeoxyglucose in differential diagnosis and staging of pancreatic carcinoma. Radiologe 1996; 36: 435-40.
33. Ho CL, Dehdashti F, Griffeth LK et al. FDG-PET evaluation of indeterminate pancreatic masses. J Comput Assist Tomogr 1996; 20: 363-9.
34. 18FDG positron emission tomography in detection and follow-up of digestive cancers. Acta Gastroenterol Belg 1997; 60: 278-80.
35. Zimny M, Bares R, Fass J et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: A report of 106 cases. Eur J Nucl Med 1997; 24: 678-82.
36. Goldenberg DM. Radiolabeled antibodies. Scient Amer (Science & Med) 1994; 1: 64-73.